Shahid Akhter, editor, ETHealthworld spoke to Ravi Mathur, CEO, GS1 India to know more about the problem of spurious drugs and what are the steps taken to control it.
There is a huge impact of spurious drugs on global programmes: Ravi Mathur
Shahid Akhter, editor, ETHealthworld spoke to Ravi Mathur, CEO, GS1 India to know more about the problem of spurious drugs and what are the steps taken to control it.
0 Comments